Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Geriatric Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Geriatric Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 112 Pages

Report ld: 2342069

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.

The global market for Geriatric Medicines was estimated to be worth US$ 712450 million in 2023 and is forecast to a readjusted size of US$ 1150460 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030

Geriatric Medicines Market Size(US$)

M= millions and B=billions

The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Geriatric Medicines, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Geriatric Medicines by region & country, by Type, and by Application.

The Geriatric Medicines market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geriatric Medicines.

Market Segmentation

Report Metric
Details
Report Title
Geriatric Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1150460 million
CAGR(2024-2030)
7.1%
Market Size Available for Years
2024-2030
Global Geriatric Medicines Companies Covered
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Global Geriatric Medicines Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Geriatric Medicines Market, Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Global Geriatric Medicines Market, Segment by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Geriatric Medicines manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Geriatric Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Geriatric Medicines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Geriatric Medicines Product Introduction
    1.2 Global Geriatric Medicines Market Size Forecast
    1.3 Geriatric Medicines Market Trends & Drivers
        1.3.1 Geriatric Medicines Industry Trends
        1.3.2 Geriatric Medicines Market Drivers & Opportunity
        1.3.3 Geriatric Medicines Market Challenges
        1.3.4 Geriatric Medicines Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Geriatric Medicines Players Revenue Ranking (2023)
    2.2 Global Geriatric Medicines Revenue by Company (2019-2024)
    2.3 Key Companies Geriatric Medicines Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Geriatric Medicines Product Offered
    2.5 Key Companies Time to Begin Mass Production of Geriatric Medicines
    2.6 Geriatric Medicines Market Competitive Analysis
        2.6.1 Geriatric Medicines Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Geriatric Medicines Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Analgesics
        3.1.2 Antihypertensives
        3.1.3 Statins
        3.1.4 Antidiabetics
        3.1.5 Proton Pump Inhibitor
        3.1.6 Anticoagulant
        3.1.7 Antipsychotics
        3.1.8 Antidepressants
    3.2 Global Geriatric Medicines Sales Value by Type
        3.2.1 Global Geriatric Medicines Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Geriatric Medicines Sales Value, by Type (2019-2030)
        3.2.3 Global Geriatric Medicines Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Cardiovascular diseases
        4.1.2 Arthritis
        4.1.3 Neurological Disorders
        4.1.4 Cancer
        4.1.5 Osteoporosis
        4.1.6 Respiratory
        4.1.7 Other
    4.2 Global Geriatric Medicines Sales Value by Application
        4.2.1 Global Geriatric Medicines Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Geriatric Medicines Sales Value, by Application (2019-2030)
        4.2.3 Global Geriatric Medicines Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Geriatric Medicines Sales Value by Region
        5.1.1 Global Geriatric Medicines Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Geriatric Medicines Sales Value by Region (2019-2024)
        5.1.3 Global Geriatric Medicines Sales Value by Region (2025-2030)
        5.1.4 Global Geriatric Medicines Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Geriatric Medicines Sales Value, 2019-2030
        5.2.2 North America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Geriatric Medicines Sales Value, 2019-2030
        5.3.2 Europe Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Geriatric Medicines Sales Value, 2019-2030
        5.4.2 Asia Pacific Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Geriatric Medicines Sales Value, 2019-2030
        5.5.2 South America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Geriatric Medicines Sales Value, 2019-2030
        5.6.2 Middle East & Africa Geriatric Medicines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Geriatric Medicines Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Geriatric Medicines Sales Value
    6.3 United States
        6.3.1 United States Geriatric Medicines Sales Value, 2019-2030
        6.3.2 United States Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Geriatric Medicines Sales Value, 2019-2030
        6.4.2 Europe Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Geriatric Medicines Sales Value, 2019-2030
        6.5.2 China Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Geriatric Medicines Sales Value, 2019-2030
        6.6.2 Japan Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Geriatric Medicines Sales Value, 2019-2030
        6.7.2 South Korea Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Geriatric Medicines Sales Value, 2019-2030
        6.8.2 Southeast Asia Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Geriatric Medicines Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Geriatric Medicines Sales Value, 2019-2030
        6.9.2 India Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Geriatric Medicines Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Eli Lilly and Company
        7.1.1 Eli Lilly and Company Profile
        7.1.2 Eli Lilly and Company Main Business
        7.1.3 Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
        7.1.4 Eli Lilly and Company Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.1.5 Eli Lilly and Company Recent Developments
    7.2 AstraZeneca
        7.2.1 AstraZeneca Profile
        7.2.2 AstraZeneca Main Business
        7.2.3 AstraZeneca Geriatric Medicines Products, Services and Solutions
        7.2.4 AstraZeneca Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.2.5 AstraZeneca Recent Developments
    7.3 Boehringer Ingelheim
        7.3.1 Boehringer Ingelheim Profile
        7.3.2 Boehringer Ingelheim Main Business
        7.3.3 Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
        7.3.4 Boehringer Ingelheim Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.3.5 Abbott Laboratories Recent Developments
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Profile
        7.4.2 Abbott Laboratories Main Business
        7.4.3 Abbott Laboratories Geriatric Medicines Products, Services and Solutions
        7.4.4 Abbott Laboratories Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.4.5 Abbott Laboratories Recent Developments
    7.5 Sanofi
        7.5.1 Sanofi Profile
        7.5.2 Sanofi Main Business
        7.5.3 Sanofi Geriatric Medicines Products, Services and Solutions
        7.5.4 Sanofi Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.5.5 Sanofi Recent Developments
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Profile
        7.6.2 Bristol-Myers Squibb Main Business
        7.6.3 Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
        7.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.6.5 Bristol-Myers Squibb Recent Developments
    7.7 Merck
        7.7.1 Merck Profile
        7.7.2 Merck Main Business
        7.7.3 Merck Geriatric Medicines Products, Services and Solutions
        7.7.4 Merck Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.7.5 Merck Recent Developments
    7.8 Novartis
        7.8.1 Novartis Profile
        7.8.2 Novartis Main Business
        7.8.3 Novartis Geriatric Medicines Products, Services and Solutions
        7.8.4 Novartis Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.8.5 Novartis Recent Developments
    7.9 Pfizer
        7.9.1 Pfizer Profile
        7.9.2 Pfizer Main Business
        7.9.3 Pfizer Geriatric Medicines Products, Services and Solutions
        7.9.4 Pfizer Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.9.5 Pfizer Recent Developments
    7.10 GSK
        7.10.1 GSK Profile
        7.10.2 GSK Main Business
        7.10.3 GSK Geriatric Medicines Products, Services and Solutions
        7.10.4 GSK Geriatric Medicines Revenue (US$ Million) & (2019-2024)
        7.10.5 GSK Recent Developments

8 Industry Chain Analysis
    8.1 Geriatric Medicines Industrial Chain
    8.2 Geriatric Medicines Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Geriatric Medicines Sales Model
        8.5.2 Sales Channel
        8.5.3 Geriatric Medicines Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Geriatric Medicines Market Trends
    Table 2. Geriatric Medicines Market Drivers & Opportunity
    Table 3. Geriatric Medicines Market Challenges
    Table 4. Geriatric Medicines Market Restraints
    Table 5. Global Geriatric Medicines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Geriatric Medicines Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Geriatric Medicines Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Geriatric Medicines Product Type
    Table 9. Key Companies Time to Begin Mass Production of Geriatric Medicines
    Table 10. Global Geriatric Medicines Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Geriatric Medicines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Geriatric Medicines Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Geriatric Medicines Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Geriatric Medicines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Geriatric Medicines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Geriatric Medicines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Geriatric Medicines Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Geriatric Medicines Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Geriatric Medicines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Geriatric Medicines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Geriatric Medicines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Geriatric Medicines Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Geriatric Medicines Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Geriatric Medicines Sales Value by Region (2019-2024) & (%)
    Table 27. Global Geriatric Medicines Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Geriatric Medicines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Geriatric Medicines Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Geriatric Medicines Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eli Lilly and Company Basic Information List
    Table 32. Eli Lilly and Company Description and Business Overview
    Table 33. Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Geriatric Medicines Business of Eli Lilly and Company (2019-2024)
    Table 35. Eli Lilly and Company Recent Developments
    Table 36. AstraZeneca Basic Information List
    Table 37. AstraZeneca Description and Business Overview
    Table 38. AstraZeneca Geriatric Medicines Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Geriatric Medicines Business of AstraZeneca (2019-2024)
    Table 40. AstraZeneca Recent Developments
    Table 41. Boehringer Ingelheim Basic Information List
    Table 42. Boehringer Ingelheim Description and Business Overview
    Table 43. Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Geriatric Medicines Business of Boehringer Ingelheim (2019-2024)
    Table 45. Boehringer Ingelheim Recent Developments
    Table 46. Abbott Laboratories Basic Information List
    Table 47. Abbott Laboratories Description and Business Overview
    Table 48. Abbott Laboratories Geriatric Medicines Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Geriatric Medicines Business of Abbott Laboratories (2019-2024)
    Table 50. Abbott Laboratories Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Geriatric Medicines Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Geriatric Medicines Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Bristol-Myers Squibb Basic Information List
    Table 57. Bristol-Myers Squibb Description and Business Overview
    Table 58. Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Geriatric Medicines Business of Bristol-Myers Squibb (2019-2024)
    Table 60. Bristol-Myers Squibb Recent Developments
    Table 61. Merck Basic Information List
    Table 62. Merck Description and Business Overview
    Table 63. Merck Geriatric Medicines Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Geriatric Medicines Business of Merck (2019-2024)
    Table 65. Merck Recent Developments
    Table 66. Novartis Basic Information List
    Table 67. Novartis Description and Business Overview
    Table 68. Novartis Geriatric Medicines Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Geriatric Medicines Business of Novartis (2019-2024)
    Table 70. Novartis Recent Developments
    Table 71. Pfizer Basic Information List
    Table 72. Pfizer Description and Business Overview
    Table 73. Pfizer Geriatric Medicines Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Geriatric Medicines Business of Pfizer (2019-2024)
    Table 75. Pfizer Recent Developments
    Table 76. GSK Basic Information List
    Table 77. GSK Description and Business Overview
    Table 78. GSK Geriatric Medicines Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Geriatric Medicines Business of GSK (2019-2024)
    Table 80. GSK Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Geriatric Medicines Downstream Customers
    Table 84. Geriatric Medicines Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Geriatric Medicines Product Picture
    Figure 2. Global Geriatric Medicines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Geriatric Medicines Report Years Considered
    Figure 5. Global Geriatric Medicines Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Geriatric Medicines Revenue in 2023
    Figure 7. Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Analgesics Picture
    Figure 9. Antihypertensives Picture
    Figure 10. Statins Picture
    Figure 11. Antidiabetics Picture
    Figure 12. Proton Pump Inhibitor Picture
    Figure 13. Anticoagulant Picture
    Figure 14. Antipsychotics Picture
    Figure 15. Antidepressants Picture
    Figure 16. Global Geriatric Medicines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Geriatric Medicines Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Product Picture of Cardiovascular diseases
    Figure 19. Product Picture of Arthritis
    Figure 20. Product Picture of Neurological Disorders
    Figure 21. Product Picture of Cancer
    Figure 22. Product Picture of Osteoporosis
    Figure 23. Product Picture of Respiratory
    Figure 24. Product Picture of Other
    Figure 25. Global Geriatric Medicines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Geriatric Medicines Sales Value Market Share by Application, 2023 & 2030
    Figure 27. North America Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Geriatric Medicines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Geriatric Medicines Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Geriatric Medicines Sales Value (%), (2019-2030)
    Figure 38. United States Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Geriatric Medicines Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Geriatric Medicines Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Geriatric Medicines Sales Value by Application (%), 2023 VS 2030
    Figure 59. Geriatric Medicines Industrial Chain
    Figure 60. Geriatric Medicines Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation

Description

Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.

The global market for Geriatric Medicines was estimated to be worth US$ 712450 million in 2023 and is forecast to a readjusted size of US$ 1150460 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030

Market Segmentation

Related Reports

Global Geriatric Medicines Market Research Report 2023
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2023-07-25
Pages: 94
USD 2900.00
(Single User License)
Global Geriatric Medicines Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It
Published: 2023-05-30
Pages: 108
USD 5600.00
(Single User License)
Global Geriatric Medicines Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2023-07-25
Pages: 101
USD 3350.00
(Single User License)
Global Geriatric Medicines Market Insights, Forecast to 2029
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2023-08-28
Pages: 110
USD 4900.00
(Single User License)
Geriatric Medicines - Global Market Insights and Sales Trends 2024
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2023-11-15
Pages: 102
USD 3350.00
(Single User License)
Global Geriatric Medicines Market Research Report 2024
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2024-01-05
Pages: 81
USD 2900.00
(Single User License)
Global Geriatric Medicines Market Insights, Forecast to 2030
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older pe
Published: 2024-04-25
Pages: 109
USD 4900.00
(Single User License)
Global Geriatric Medicines Market Research Report 2025
The global market for Geriatric Medicines was valued at US$ 811030 million in the year 2024 and is p
Published: 2025-02-27
Pages: 76
USD 2900.00
(Single User License)
Geriatric Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Geriatric Medicines was estimated to be worth US$ 811030 million in 2024 and i
Published: 2025-02-27
Pages: 99
USD 3950.00
(Single User License)